PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14638498-7	2003	The bla(KPC-2) determinant was cloned in E. coli and conferred resistance to imipenem, meropenem, extended-spectrum cephalosporins, and aztreonam.	Meropenem	87-96	KPC-2	Escherichia coli	8-13	
14638498-10	2003	KPC-2 had the highest affinity for meropenem.	Meropenem	35-44	KPC-2	Escherichia coli	0-5	
34324652-8	2021	The isolates with high MICs had significantly higher blaKPC-2 expression, which corresponds to phenotypic meropenem inactivation.	Meropenem	106-115	KPC-2	Escherichia coli	53-61	
30258039-8	2018	Lower MICs for ceftriaxone, cefepime, aztreonam, meropenem, and imipenem for the mutated KPC-2-producing isolates were observed compared to those of the isolates producing a wild-type KPC-2.	Meropenem	49-58	KPC-2	Escherichia coli	89-94	
35130728-3	2022	Here, we reported that IS26-mediated amplification of blaKPC-2 rapidly and robustly gave rise to carbapenem hyperresistant phenotypes in an Escherichia coli clinical strain following sublethal meropenem or tobramycin preexposure.	Meropenem	193-202	KPC-2	Escherichia coli	54-62